Sign in
Taking people in United StatesNo phase

Cardiac Structure and Function in MPS

Key facts

Who runs it
Children's Hospital of Orange County
Where
Minneapolis, Orange, and St Louis, United StatesSee the 3 sites
Trial code
Status
Recruiting
People taking part
240 people, planned
Started
1 Sept 2025
Expected to end
30 Apr 2030
Type of study
Observational, 2 groups
Record updated
21 October 2026

Who can take part

Age
0 years to 99 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Any Participant with a molecularly confirmed diagnosis of mucopolysaccharidosis is eligible to enroll in this study
  • Any healthy participant without a diagnosis of mucopolysaccharidosis whose age and biological sex can be matched with an enrolled mucopolysaccharidosis participant
  • Parental / patient informed consent

Who cannot take part

  • Any reason that the investigators would deem a patient not eligible to participate in this study
  • Inability to participate in the assessments required for this study

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 0 and 99 years old?

Where in United States

  • University of MinnesotaMinneapolis, United StatesContact: Donald Dengel, PhDNot yet recruiting
  • Children's Hospital of Orange CountyOrange, United StatesContact: Nina MovsesyanTaking people
  • Saint Louis UniversitySt Louis, United StatesContact: Adriana M Montano, PhDTaking people

About the trial

What the trial wants to find out

The purpose of this study is to better understand how heart and blood vessel problems develop in people with Mucopolysaccharidosis (MPS). The investigators are looking at certain substances in the body called GAGs and proteoglycans to see how they affect the heart. The investigators also want to find reliable blood and urine markers that can help us track heart health and guide future treatments.

Read full original descriptionShow less

This study aims to answer two main questions:

1. Do people with MPS show faster changes in their blood vessels over time (such as thickening or stiffening of the carotid artery) compared to people without MPS? 2. Do people with MPS have higher levels of certain proteins in their blood (such as clusterin and inflammatory markers) that are linked to blood vessel changes?

What participants will do?

Participants will complete the following tests once a year for 4 years:

* Carotid ultrasound: an imaging test that looks at the blood vessels in the neck. * Echocardiogram: an ultrasound of the heart. * Blood draw * Urine collection

These tests help the investigators track changes in heart and blood vessel health over time.

The 2 groups in the trial

  • MPS

    Participants diagnosed with MPS I or MPS IVA

  • Control

    Participants who do not have an MPS diagnosis

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Cardiovascular Structure and Function in Mucopolysaccharidosis Types I and IVA
Criteria questions
Built from NCT07361536, who can take part
Record updated
21 October 2026